Aaron Ondrey, Chief Financial Officer at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 7,489 shares at $5.29 ($40K) on 2025-04-04, disclosed to the SEC on 2025-04-08.
Open-market sale of $40k RCKT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.